Establishment Labs (ESTA) Projected to Post Quarterly Earnings on Wednesday

Establishment Labs (NASDAQ:ESTA) is anticipated to post its quarterly earnings results after the market closes on Wednesday, February 26th. Analysts expect Establishment Labs to post earnings of ($0.64) per share and revenue of $44.45 million for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link.

Establishment Labs Price Performance

Shares of NASDAQ ESTA opened at $33.41 on Monday. The stock has a fifty day moving average of $37.89 and a 200-day moving average of $41.43. Establishment Labs has a fifty-two week low of $28.16 and a fifty-two week high of $60.12. The stock has a market cap of $935.56 million, a PE ratio of -12.95 and a beta of 1.12. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62.

Analysts Set New Price Targets

Separately, Stephens raised Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. One analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $60.60.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.